{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:30:21Z","timestamp":1790191821398,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00210-025-04665-z","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T10:17:04Z","timestamp":1762942624000},"page":"5761-5776","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["CRISPR screens reveal YAP\/TEAD axis as a mediator of drug-tolerant cells in EGFR-mutant NSCLC"],"prefix":"10.1007","volume":"399","author":[{"given":"Muhammed","family":"Yusuf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"4665_CR1","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1038\/s41467-021-21884-z","volume":"12","author":"AF Aissa","year":"2021","unstructured":"Aissa AF et al (2021) Single-cell transcriptional changes associated with drug tolerance and response to combination therapies in cancer. Nat Commun 12:1628","journal-title":"Nat Commun"},{"key":"4665_CR2","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1083\/jcb.200703010","volume":"177","author":"M Curto","year":"2007","unstructured":"Curto M, Cole BK, Lallemand D, Liu CH, McClatchey AI (2007) Contact-dependent inhibition of EGFR signaling by Nf2\/Merlin. J Cell Biol 177:893\u2013903","journal-title":"J Cell Biol"},{"key":"4665_CR3","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10137","volume":"474","author":"S Dupont","year":"2011","unstructured":"Dupont S et al (2011) Role of YAP\/TAZ in mechanotransduction. Nature 474:179\u2013183","journal-title":"Nature"},{"key":"4665_CR4","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1126\/science.1141478","volume":"316","author":"JA Engelman","year":"2007","unstructured":"Engelman JA et al (2007) MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science 316:1039\u20131043","journal-title":"Science"},{"key":"4665_CR5","doi-asserted-by":"publisher","first-page":"27928","DOI":"10.1074\/jbc.M115.692285","volume":"290","author":"ML Finch-Edmondson","year":"2015","unstructured":"Finch-Edmondson ML et al (2015) TAZ protein accumulation is negatively regulated by YAP abundance in mammalian cells. J Biol Chem 290:27928\u201327938","journal-title":"J Biol Chem"},{"key":"4665_CR6","first-page":"4399","volume":"10","author":"A Kaneda","year":"2020","unstructured":"Kaneda A et al (2020) The novel potent TEAD inhibitor, K-975, inhibits YAP1\/TAZ-TEAD protein-protein interactions and exerts an antitumor effect on malignant pleural mesothelioma. Am J Cancer Res 10:4399\u20134415","journal-title":"Am J Cancer Res"},{"key":"4665_CR7","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nbt.2800","volume":"32","author":"H Koike-Yusa","year":"2014","unstructured":"Koike-Yusa H, Li Y, Tan EP, Velasco-Herrera Mdel C, Yusa K (2014) Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library. Nat Biotechnol 32:267\u2013273","journal-title":"Nat Biotechnol"},{"key":"4665_CR8","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nature14136","volume":"517","author":"S Konermann","year":"2015","unstructured":"Konermann S et al (2015) Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature 517:583\u2013588","journal-title":"Nature"},{"key":"4665_CR9","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ccell.2019.12.006","volume":"37","author":"KJ Kurppa","year":"2020","unstructured":"Kurppa KJ et al (2020) Treatment-induced tumor dormancy through YAPmediated transcriptional reprogramming of the apoptotic pathway. Cancer Cell 37:104-122.e112","journal-title":"Cancer Cell"},{"key":"4665_CR10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R (2014) Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 15:178\u2013196","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4665_CR11","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41416-019-0573-8","volume":"121","author":"A Leonetti","year":"2019","unstructured":"Leonetti A et al (2019) Resistance mechanisms to osimertinib in EGFRmutated non-small cell lung cancer. Br J Cancer 121:725\u2013737","journal-title":"Br J Cancer"},{"key":"4665_CR12","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1186\/s13059-014-0554-4","volume":"15","author":"W Li","year":"2014","unstructured":"Li W et al (2014) MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens. Genome Biol 15:554","journal-title":"Genome Biol"},{"key":"4665_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101411","volume":"23","author":"Z Li","year":"2020","unstructured":"Li Z et al (2020) Human lung adenocarcinoma-derived organoid models for drug screening. iScience 23:101411","journal-title":"iScience"},{"key":"4665_CR14","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.tibs.2017.09.003","volume":"42","author":"KC Lin","year":"2017","unstructured":"Lin KC, Park HW, Guan KL (2017) Regulation of the hippo pathway transcription factor TEAD. Trends Biochem Sci 42:862\u2013872","journal-title":"Trends Biochem Sci"},{"key":"4665_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.lungcan.2019.09.019","volume":"137","author":"C Mehlman","year":"2019","unstructured":"Mehlman C et al (2019) Resistance mechanisms to osimertinib in EGFRmutated advanced non-small-cell lung cancer: a multicentric retrospective French study. Lung Cancer 137:149\u2013156","journal-title":"Lung Cancer"},{"key":"4665_CR16","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1056\/NEJMoa0810699","volume":"361","author":"TS Mok","year":"2009","unstructured":"Mok TS et al (2009) Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 361:947\u2013957","journal-title":"N Engl J Med"},{"key":"4665_CR17","doi-asserted-by":"publisher","first-page":"7807","DOI":"10.1158\/0008-5472.CAN-07-0681","volume":"67","author":"A Ogino","year":"2007","unstructured":"Ogino A et al (2007) Emergence of epidermal growth factor receptorT790M mutation during chronic exposure to gefitinib in a non small cell lung cancer cell line. Cancer Res 67:7807\u20137814","journal-title":"Cancer Res"},{"key":"4665_CR18","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41586-021-03796-6","volume":"596","author":"Y Oren","year":"2021","unstructured":"Oren Y et al (2021) Cycling cancer persister cells arise from lineages with distinct programs. Nature 596:576\u2013582","journal-title":"Nature"},{"key":"4665_CR19","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s43018-021-00195-8","volume":"2","author":"A Passaro","year":"2021","unstructured":"Passaro A, Janne PA, Mok T (2021) Overcoming therapy resistance in EGFR-mutant lung cancer. Nat Cancer 2:377\u2013391","journal-title":"Nat Cancer"},{"key":"4665_CR20","doi-asserted-by":"publisher","first-page":"6399","DOI":"10.1038\/s41388-019-0887-2","volume":"38","author":"S Raoof","year":"2019","unstructured":"Raoof S et al (2019) Targeting FGFR overcomes EMT-mediated resistance in EGFR mutant non-small cell lung cancer. Oncogene 38:6399\u20136413","journal-title":"Oncogene"},{"key":"4665_CR21","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1158\/1078-0432.CCR-19-3563","volume":"26","author":"AJ Schoenfeld","year":"2020","unstructured":"Schoenfeld AJ et al (2020) Tumor analyses reveal squamous transformation and off-target alterations as early resistance mechanisms to first-line Osimertinib in EGFR-mutant lung cancer. Clin Cancer Res 26:2654\u20132663","journal-title":"Clin Cancer Res"},{"key":"4665_CR22","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.cell.2020.10.027","volume":"183","author":"S Shen","year":"2020","unstructured":"Shen S, Vagner S, Robert C (2020) Persistent cancer cells: the deadly survivors. Cell 183:860\u2013874","journal-title":"Cell"},{"key":"4665_CR23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1158\/2159-8290.CD-13-0642","volume":"4","author":"H Shi","year":"2014","unstructured":"Shi H et al (2014) Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy. Cancer Discov 4:80\u201393","journal-title":"Cancer Discov"},{"key":"4665_CR24","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nature11183","volume":"487","author":"R Straussman","year":"2012","unstructured":"Straussman R et al (2012) Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature 487:500\u2013504","journal-title":"Nature"},{"key":"4665_CR25","doi-asserted-by":"publisher","first-page":"5364","DOI":"10.1158\/1538-7445.AM2022-5364","volume":"82","author":"TT Tang","year":"2022","unstructured":"Tang TT, Post L (2022) The TEAD autopalmitoylation inhibitor VT3989 improves efficacy and increases durability of efficacy of osimertinib in preclinical EGFR mutant tumor models. Cancer Res 82:5364","journal-title":"Cancer Res"},{"key":"4665_CR26","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.celrep.2016.09.079","volume":"17","author":"K Tzelepis","year":"2016","unstructured":"Tzelepis K et al (2016) A CRISPR dropout screen identifies genetic vulnerabilities and therapeutic targets in acute myeloid leukemia. Cell Rep 17:1193\u20131205","journal-title":"Cell Rep"},{"key":"4665_CR27","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1242\/dev.102376","volume":"141","author":"X Varelas","year":"2014","unstructured":"Varelas X (2014) The hippo pathway effectors TAZ and YAP in development, homeostasis and disease. Development 141:1614\u20131626","journal-title":"Development"},{"key":"4665_CR28","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","volume":"575","author":"N Vasan","year":"2019","unstructured":"Vasan N, Baselga J, Hyman DM (2019) A view on drug resistance in cancer. Nature 575:299\u2013309","journal-title":"Nature"},{"key":"4665_CR29","doi-asserted-by":"publisher","first-page":"6630","DOI":"10.1158\/1078-0432.CCR-09-1001","volume":"15","author":"W Wang","year":"2009","unstructured":"Wang W et al (2009) Crosstalk to stromal fibroblasts induces resistance of lung cancer to epidermal growth factor receptor tyrosine kinase inhibitors. Clin, Cancer Res 15:6630\u20136638","journal-title":"Clin, Cancer Res"},{"key":"4665_CR30","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1002\/cpz1.90","volume":"1","author":"Z Xie","year":"2021","unstructured":"Xie Z et al (2021) Gene set knowledge discovery with Enrichr. Curr Protoc 1:e90","journal-title":"Curr Protoc"},{"key":"4665_CR31","doi-asserted-by":"publisher","first-page":"13355","DOI":"10.1074\/jbc.M900843200","volume":"284","author":"H Zhang","year":"2009","unstructured":"Zhang H et al (2009) TEADtranscription factors mediate the function ofTAZ in cell growth and epithelial-mesenchymal transition. J Biol Chem 284:13355\u201313362","journal-title":"J Biol Chem"},{"key":"4665_CR32","doi-asserted-by":"publisher","unstructured":"Zhang W, Nandakumar N, Shi Y, Manzano M, Smith A, Graham G, Gupta S, Vietsch EE, Laughlin SZ, Wadhwa M, Chetram M, Joshi M, Wang J, Saltz J, Zeng J, Bosselut R (2015) Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma. Sci Signal 8(366):ra42. https:\/\/doi.org\/10.1126\/scisignal.2005829","DOI":"10.1126\/scisignal.2005829"},{"key":"4665_CR33","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1101\/gad.1843810","volume":"24","author":"B Zhao","year":"2010","unstructured":"Zhao B, Li L, Tumaneng K, Wang CY, Guan KL (2010) Acoordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). Genes Dev 24:72\u201385","journal-title":"Genes Dev"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04665-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04665-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04665-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T03:06:23Z","timestamp":1775099183000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04665-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4665"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04665-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7164924\/v1","asserted-by":"object"}]},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"19 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate, and consent to publish"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}